Brazil vs Zambia: The number of people with susceptibility test result for rifampicin
Brazil
24,394
in 2021
Zambia
16,922
in 2021
Brazil rank
14th
Zambia rank
17th
The number of people with susceptibility test result for rifampicin over time
- Brazil
- Zambia
How they compare
Brazil currently reports 24,394 against 16,922 in Zambia, a difference of 7,472.
That makes Brazil's figure about 1.4 times Zambia's.
Across all 5 years both countries report, Brazil has been ahead every year.
Brazil ranks 14th and Zambia ranks 17th of 155 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20,251 | 10,301 | 9,950 | Brazil |
| 2020s | 24,076 | 16,156 | 7,920 | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brazil or Zambia?
- Brazil, at 24,394 against 16,922 in Zambia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brazil and Zambia?
- 7,472, with Brazil ahead.
- How many years of comparable data are there for Brazil and Zambia?
- 5 years are reported by both, from 2017 to 2021.
- How do Brazil and Zambia rank globally for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 14th and Zambia ranks 17th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.